BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15104770)

  • 1. Outcomes following percutaneous coronary intervention in patients previously considered "without option": a subgroup analysis of the PACIFIC Trial.
    Lowe HC; Oesterle SN; He KL; Macneill BD; Burkhoff D
    J Interv Cardiol; 2004 Apr; 17(2):87-91. PubMed ID: 15104770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
    Hordijk-Trion M; Lenzen M; Wijns W; de Jaegere P; Simoons ML; Scholte op Reimer WJ; Bertrand ME; Mercado N; Boersma E;
    Eur Heart J; 2006 Mar; 27(6):671-8. PubMed ID: 16423872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase I feasibility study.
    Stone GW; St Goar FG; Taussig A; Power JA; Kosinski E; Shawl F
    Am Heart J; 2001 Oct; 142(4):679-83. PubMed ID: 11579359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
    Lee MS; Kapoor N; Jamal F; Czer L; Aragon J; Forrester J; Kar S; Dohad S; Kass R; Eigler N; Trento A; Shah PK; Makkar RR
    J Am Coll Cardiol; 2006 Feb; 47(4):864-70. PubMed ID: 16487857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement.
    Botman KJ; Pijls NH; Bech JW; Aarnoudse W; Peels K; van Straten B; Penn O; Michels HR; Bonnier H; Koolen JJ
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):184-91. PubMed ID: 15390344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG; Ioannidis JP
    Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice.
    Benzer W; Höfer S; Oldridge NB
    Herz; 2003 Aug; 28(5):421-8. PubMed ID: 12928741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta.
    Thompson CR; Humphries KH; Gao M; Galbraith PD; Norris C; Carere RG; Knudtson ML; Ghali WA;
    Can J Cardiol; 2004 Dec; 20(14):1417-23. PubMed ID: 15614334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry.
    Goldman LE; Okrainec K; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Del Core M; Duerr R; Huynh T; Smilovitch M; Sedlis S; Brown DL; Brieger D;
    Can J Cardiol; 2004 May; 20(6):608-12. PubMed ID: 15152290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
    White HD; Assmann SF; Sanborn TA; Jacobs AK; Webb JG; Sleeper LA; Wong CK; Stewart JT; Aylward PE; Wong SC; Hochman JS
    Circulation; 2005 Sep; 112(13):1992-2001. PubMed ID: 16186436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention.
    Davidavicius G; Van Praet F; Mansour S; Casselman F; Bartunek J; Degrieck I; Wellens F; De Geest R; Vanermen H; Wijns W; De Bruyne B
    Circulation; 2005 Aug; 112(9 Suppl):I317-22. PubMed ID: 16159838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting.
    Hassan A; Buth KJ; Baskett RJ; Ali IS; Maitland A; Sullivan JA; Ghali WA; Hirsch GM
    Am Heart J; 2005 Nov; 150(5):1026-31. PubMed ID: 16290991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.